Synopsys, Inc. $SNPS Shares Purchased by OMERS ADMINISTRATION Corp

OMERS ADMINISTRATION Corp raised its holdings in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 0.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 308,197 shares of the semiconductor company’s stock after acquiring an additional 1,994 shares during the quarter. OMERS ADMINISTRATION Corp owned approximately 0.16% of Synopsys worth $122,194,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Sankala Group LLC purchased a new position in shares of Synopsys during the 4th quarter worth approximately $25,000. Thurston Springer Miller Herd & Titak Inc. purchased a new position in Synopsys during the fourth quarter worth $28,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Synopsys in the fourth quarter worth $28,000. Atlas Capital Advisors Inc. acquired a new position in shares of Synopsys in the fourth quarter worth $32,000. Finally, Geneos Wealth Management Inc. boosted its stake in shares of Synopsys by 151.5% during the first quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company’s stock valued at $33,000 after acquiring an additional 50 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Insider Transactions at Synopsys

In other news, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This represents a 16.29% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.56% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently commented on the company. KeyCorp reiterated an “overweight” rating on shares of Synopsys in a research report on Thursday, May 28th. Stifel Nicolaus upped their target price on shares of Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Berenberg Bank set a $633.00 price target on shares of Synopsys in a research note on Wednesday, May 27th. Rosenblatt Securities lifted their price target on shares of Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a report on Tuesday, May 26th. Finally, Zacks Research raised shares of Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $570.06.

View Our Latest Stock Analysis on SNPS

Synopsys Price Performance

SNPS stock opened at $373.47 on Friday. The stock has a market capitalization of $71.51 billion, a price-to-earnings ratio of 86.45, a price-to-earnings-growth ratio of 2.19 and a beta of 1.22. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 52-week low of $366.00 and a 52-week high of $651.73. The stock’s fifty day simple moving average is $456.13 and its 200-day simple moving average is $455.25.

Synopsys (NASDAQ:SNPSGet Free Report) last released its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same period in the prior year, the firm posted $3.67 earnings per share. The business’s quarterly revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts expect that Synopsys, Inc. will post 10.65 EPS for the current year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Recommended Stories

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.